Industry trends, practical guides, and product updates from the WeGuide team: clinical trials, patient engagement, wearables, registries, and more.

WeGuide will receive A$1.9 million to build a world first platform in developing commercial multi-modal biomarkers. Building their first use case with NeuRA on mobility recovery, the platform accelerates regulatory-approved biomarker development for researchers, health organisations and pharmaceutical companies working to bring precision medicine tools to patients and trial participants.
Read more ›Product updates, partnerships, and company news from WeGuide.
Guides, benchmarks, and practical playbooks for running better clinical trials.
Engaging and retaining participants across clinical research and digital health programs.
Wearables and digital health technologies in research: devices, digital biomarkers and endpoints, data quality.
Every WeGuide article, organized by topic. Choose a category to see its full archive.